Conference
A novel, oral 5HT3 partial agonist, DDP733, improves overall response in patients with irritable bowel syndrome and constipation (IBS-c): A randomized, double blind, placebo-controlled, parallel-group, dose-ranging study
Authors
Paterson WG; Ford D; Ganguli SC; Reynolds RP; Pliamm L; O'Mahony M; Pare P; Nurbhai S; Feagan B; Landau SB
Volume
134
Pagination
pp. A546-A547
Publisher
W B SAUNDERS CO-ELSEVIER INC
Publication Date
April 1, 2008
Conference proceedings
GASTROENTEROLOGY
Issue
4
ISSN
0016-5085